Advances in the Management of Recurrent Ovarian Cancer What is your opinion about the outlook for epidermal growth factor receptor antagonists (EGFR), incl MORE»
Advances in the Management of Recurrent Ovarian Cancer We have several patients in whom we've tried IP chemotherapy in the second line setting. We have bee MORE»
Medulloblastoma I have a patient who is a 29-year-old male with a 3-cm cerebellar medulloblastoma grossly resected. MORE»
OncologyCorner.com is a specialty portal page on CMEcorner.com,
an educational service of Medical Communications Media, Inc.
